| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| Conditions of Growth, Economic Analysis - Research Report on SandRidge Energy Inc. and Boston Scientific Corporation | | 11 | MarketWire |
| HONG KONG -- (Marketwire) -- 05/25/12 -- Today, www.EquityLeader.com introduced research coverage of SandRidge Energy Inc. (NYSE: SD) and Boston Scientific Corporation (NYSE: BSX). Full research reports...
Mehr lesen zu:
Conditions of Growth, Economic Analysis - Research Report on SandRidge Energy Inc. and Boston Scientific Corporation | |
| 25.05.
| Plan to Speed Up FDA Reviews Will Look to Benefit Medical Devices Companies / Five Star Equities Provides Stock Research on Boston Scientific and MELA Sciences | | 34 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 05/25/12 -- A recent plan to speed up reviews of new drugs and medical devices will look to benefit companies in the Medical Devices Industry. "To get lifesaving drugs...
Mehr lesen zu:
Plan to Speed Up FDA Reviews Will Look to Benefit Medical Devices Companies / Five Star Equities Provides Stock Research on Boston Scientific and MELA Sciences | |
| 25.05.
| Boston Scientific and MELA Sciences Look to Benefit From Plan to Speed Up FDA Reviews / Five Star Equities Provides Stock Research on Boston Scientific and MELA Sciences | | 34 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 05/25/12 -- A recent plan to speed up reviews of new drugs and medical devices will look to benefit companies in the Medical Devices Industry. "To get lifesaving drugs...
Mehr lesen zu:
Boston Scientific and MELA Sciences Look to Benefit From Plan to Speed Up FDA Reviews / Five Star Equities Provides Stock Research on Boston Scientific and MELA Sciences | |
| 22.05.
| Possible Bullish Inside Day Candle Pattern Detected for Boston Scientific | | 1 | SmarTrend |
| 18.05.
| Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ® | | 41 | PR Newswire |
| NATICK, Mass., May 18, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces that seven abstracts and additional clinical data analyses will be presented at Digestive Disease Week®...
Mehr lesen zu:
Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ® | |
| 18.05.
| Boston Scientific (BSX) Reports Encouraging Data from PROMUS Element Study; | | - | StreetInsider.com |
| 18.05.
| Boston Scientific: PROMUS Element Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study | | - | Benzinga.com |
| 18.05.
| Boston Scientific Reports 2-yr Results From PLATINUM Small Vessel Study | | 64 | AFX News |
| WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) announced two-year
results from the PLATINUM Small Vessel study, demonstrating excellent safety and
effectiveness outcomes for the 2.25...
Mehr lesen zu:
Boston Scientific Reports 2-yr Results From PLATINUM Small Vessel Study | |
| 18.05.
| Boston Scientific wins approval for new leg stent | | 1 | Yahoo-USA |
| 17.05.
| Boston Scientific Announces FDA Approval and U.S. Launch of EPIC Vascular Stent | | - | Benzinga.com |
| 17.05.
| Boston Scientific Announces FDA Approval And US Launch Of EPIC Vascular Stent | | 52 | AFX News |
| WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) announced U.S. Food and
Drug Administration approval and market launch of the Epic Vascular
Self-Expanding Stent System.The company noted...
Mehr lesen zu:
Boston Scientific Announces FDA Approval And US Launch Of EPIC Vascular Stent | |
| 17.05.
| Boston Scientific (BSX) Gets FDA Approval for Epic Vascular Self-Expanding Stent System | | - | StreetInsider.com |
| 17.05.
| Boston Scientific Announces FDA Approval and U.S. Launch of EPIC' Vascular Stent | | 30 | PR Newswire |
| NATICK, Mass., May 17, 2012 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) announces U.S. Food and Drug Administration approval and market launch of the Epic' Vascular Self-Expanding Stent...
Mehr lesen zu:
Boston Scientific Announces FDA Approval and U.S. Launch of EPIC' Vascular Stent | |
| 15.05.
| Boston Scientific Innova Has CE Mark | | 1 | Zacks |
| 15.05.
| One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety and Effectiveness Data of the Boston Scientific SYNERGY' Stent Versus Promus Element' Platinum Chromium Stent | | 34 | PR Newswire |
| NATICK, Massachusetts, May 15, 2012 /PRNewswire/ --
Follow-up Data from EVOLVE Trial Presented at EuroPCR; Trial is Evaluating Next-Generation Everolimus-Eluting Platinum Chromium Coronary Stent...
Mehr lesen zu:
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety and Effectiveness Data of the Boston Scientific SYNERGY' Stent Versus Promus Element' Platinum Chromium Stent | |
| 15.05.
| Boston Scientific Announces Positive Data from Lotus Transcatheter Aortic Valve Trial | | - | Benzinga.com |
| 15.05.
| Boston Scientific gibt positive Daten von einer Studie zum Transkatheter Aortenklappen-System Lotus? bekannt | | 54 | news aktuell |
| Natick, Massachusetts Und Boston (ots/PRNewswire) - Die Resultate der REPRISE-I-Studie legen nahe, dass das Aortenklappen-System die paravalvulaere Regurgitation minimiert Boston Scientific Corporation...
Mehr lesen zu:
Boston Scientific gibt positive Daten von einer Studie zum Transkatheter Aortenklappen-System Lotus? bekannt | |
| 15.05.
| Boston Scientific gibt positive Daten von einer Studie zum Transkatheter Aortenklappen-System Lotus? bekannt | | 42 | news aktuell-CH |
| Natick, Massachusetts Und Boston (ots/PRNewswire) - Die Resultate der REPRISE-I-Studie legen nahe, dass dasAortenklappen-System die paravalvulaere Regurgitation minimiert Boston Scientific Corporation...
Mehr lesen zu:
Boston Scientific gibt positive Daten von einer Studie zum Transkatheter Aortenklappen-System Lotus? bekannt | |
| 15.05.
| Boston Scientific Announces Positive Data from Lotus' Transcatheter Aortic Valve Trial | | 36 | PR Newswire |
| NATICK, Massachusetts, May 15, 2012 /PRNewswire/ --
- Results of REPRISE I Study Suggest Device Minimizes Aortic Regurgitation
Boston Scientific Corporation (NYSE: BSX) announces results from the...
Mehr lesen zu:
Boston Scientific Announces Positive Data from Lotus' Transcatheter Aortic Valve Trial | |
| 15.05.
| One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY' Stent Versus PROMUS Element' Platinum Chromium Stent | | 49 | PR Newswire |
| NATICK, Mass., May 15, 2012 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) announces that the SYNERGY' Everolimus-Eluting Bioabsorbable Polymer-Coated Platinum Chromium...
Mehr lesen zu:
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY' Stent Versus PROMUS Element' Platinum Chromium Stent | |
